Table of Contents :
• Stock Rating & Target Price
• Investment Thesis
• Fundamental Models Used
• Company Description
• Corporate Timeline
• Key Metrics (KPI ) and Recently Reported Earnings Review
• Business Highlights, Strategic Announcements & Outlook
• Quarter-over-Quarter (Q-o-Q) and Year-over-Year (Y-o-Y) Growth Analysis
• Key Catalysts Driving Growth
• Historical Financial Statement Analysis & CAGR Trends
• Quarterly Key Financial Ratios and Performance Metrics
• Annual Financial Performance Analysis: Horizontal and Vertical Financial Analysis, Trends
• Financial Forecasts
• Annual Forecasts: Income Statement
• Annual Forecasts: Cash Flow Statements
• Net Debt Levels
• A Closer Look at DCF: Our Assumptions and Methodology
• Terminal Value Calculation
• Target Price Analysis
• Valuation Multiples
• Supplementary Valuation Analysis: Multiples Approach
• Scenario/Sensitivity Analysis – Base Case , Bull Case ,Bear Case
• Holistic Peer Review & Trading Comps: Financial Data, Operational Metrics, and Valuation Multiples
• Implied Price Per Share
• Ownership Activity/ Insider Trades
• Ownership Summary
• An analysis of ESG Risk Rating
• Key Professionals
• Key Board Members
• Key Risks Considerations
• Analyst Ratings
• Analyst Industry Views
• Disclosures
Clorox (CLX) Powers Margins, But Will $1 Billion in Brand Investment Reignite Growth?
Clorox’s Q3F25 results highlight best-in-class margin management amid soft volumes, with gross margin expanding for a tenth consecutive quarter to 44%, buoyed by strong cost savings, promotional discipline, and strategic SKU exits. Adjusted EPS of $1.71 and guided full-year organic sales growth of 4–5% (including ERP inventory pull-forward) reflect the company's focus on structural margin durability rather than volume growth in a cautious consumer environment. Cleaning and Grilling segments outperformed, but Household and Pet faced transitory pressures from retailer destocking and value-tier competition, particularly in Glad. Management’s playbook—tariff mitigation via surgical pricing, reformulation, and sourcing pivots—avoids broad-based hikes, preserving brand equity. ERP deployment timing noise will cloud Q4, but digitization benefits and sales & ops alignment are strategic long-term positives. Notably, Clorox is leaning into its $1B brand investment strategy, with early success seen in Scentiva and Hidden Valley, supporting pricing power and premium tier expansion. While Clorox reaffirmed its EBIT margin expansion algorithm (25–50bps/year), topline remains elusive near term as consumers prioritize discretionary durables. With shares trading at 13.5x NTM EV/EBITDA and 25% below our FVE, we maintain Outperform but ask: can Clorox’s $1B brand investment unlock sustainable volume-led growth in FY26—or will pricing power alone continue to carry the story?
